// App-Quantinova.ai

: Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD

Researchers

Presenter

  • Alan A Martin

Principal Investigators

  • Dhvani Shah

  • Emma C Goodall

  • Melanie Schroeder

  • Nancy Risebrough

  • Kerigo Ndirangu

  • Afisi S Ismaila

Medical Centers

  • GSK, Uxbridge, United Kingdom

  • ICON Health Economics, New York, United States of America

  • GSK, Toronto, Canada

  • GSK, Brentford, United Kingdom

  • ICON Health Economics, Toronto, ON, Canada.

  • GlaxoSmithKline plc, Collegeville, United States of America

Locations

  • United Kingdom

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02164513

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved